Shots: The companies collaborated to develop AAV vectors deploying Cure Genetics’ VELP platform to develop next-generation gene therapies The focus of the pact is to provide new AAV serotypes for […]readmore
Shots: The approval is based on 12mos. results of PINNACLE FLX study assessing the WATCHMAN FLX device as an alternative to NOACs and other OAC medications. The study met its […]readmore
Shots: Arcus to receive $375M including $175M up front & $200M as equity investment at a price of $33.54/ share with a premium of 35% and is eligible to receive […]readmore
Shots: The companies together formed a multi-faceted global strategic alliance which combines the technologies of both the companies to deliver a new generation of medical functionality to wearable devices Huami […]readmore
Copyright © 2020 Digiqole. All Right Reserved.